Gene · 25913
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Aspects of Senescence and Organismal Ageing-DNA Damage Response, Telomeres, Inflammation and Chromatin. | Int J Mol Sci | 2021 | 33435578 | PubTator, text mining | PubMed |
| Telomere length as a function of age at population level parallels human survival curves. | Aging (Albany NY) | 2021 | 33431711 | PubTator, text mining | PubMed |
| Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains. | Cancer Sci | 2021 | 33426772 | PubTator, text mining | PubMed |
| CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells. | Mol Ther Nucleic Acids | 2021 | 33425489 | PubTator, text mining | PubMed |
| Comprehensive characterisation of intronic mis-splicing mutations in human cancers. | Oncogene | 2021 | 33420369 | PubTator, text mining | PubMed |
| Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation. | Nat Commun | 2021 | 33420056 | PubTator, text mining | PubMed |
| Selection of tumor‑resistant variants following sustained natural killer cell‑mediated immune stress. | Oncol Rep | 2021 | 33416152 | PubTator, text mining | PubMed |
| The State of Melanoma: Emergent Challenges and Opportunities. | Clin Cancer Res | 2021 | 33414132 | PubTator, text mining | PubMed |
| A nuclear enterprise: zooming in on nuclear organization and gene expression control in the African trypanosome. | Parasitology | 2021 | 33407981 | PubTator, text mining | PubMed |
| Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct features and a novel resistance mechanism for crizotinib. | J Cancer | 2021 | 33403024 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| The end protection problem-an unexpected twist in the tail. | Genes Dev | 2021 | 33361389 | PubTator, text mining | PubMed |
| The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. | Toxicol Appl Pharmacol | 2021 | 33359661 | PubTator, text mining | PubMed |
| Gene regulation by long non-coding RNAs and its biological functions. | Nat Rev Mol Cell Biol | 2021 | 33353982 | PubTator, text mining | PubMed |
| Roles of telomeres and telomerase in age‑related renal diseases (Review). | Mol Med Rep | 2021 | 33300081 | PubTator, text mining | PubMed |
| Analysis of telomere length variation and Shelterin complex subunit gene expression changes in ethanol-exposed human embryonic stem cells. | J Psychiatr Res | 2021 | 33243459 | PubTator, text mining | PubMed |
| A rare missense variant in protection of telomeres 1 (POT1) predisposes to a range of haematological malignancies. | Br J Haematol | 2021 | 33216348 | PubTator, text mining | PubMed |
| Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. | Toxicol In Vitro | 2021 | 33212167 | PubTator, text mining | PubMed |
| Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib. | Eur J Haematol | 2021 | 33190294 | PubTator, text mining | PubMed |
| Telomeres in toxicology: Occupational health. | Pharmacol Ther | 2021 | 33176178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/papers?page=46